Chisholm G D, Rana A
University Department of Surgery/Urology, Western General Hospital, Edinburgh, UK.
Eur Urol. 1993;24 Suppl 2:64-6. doi: 10.1159/000474393.
The outcome of conservative management in a consecutive series of 107 localized prostate cancers (mean age 73.5 years) has been analyzed. Follow-up ranged from 1 to 12 years. Following regular surveillance and no initial treatment, 3 died from prostate cancer with a median survival of 6.3 years compared to 34 who died from intercurrent disease with a median survival of only 2.6 years. The observed survival for the whole group was similar to the expected survival for an age-matched population in Scotland. This was despite the fact that the nodal status and the capsular invasion were unknown.
对连续的107例局限性前列腺癌患者（平均年龄73.5岁）进行保守治疗的结果进行了分析。随访时间为1至12年。在进行定期监测且未进行初始治疗后，3例死于前列腺癌，中位生存期为6.3年，而34例死于并发疾病，中位生存期仅为2.6年。该组观察到的生存率与苏格兰年龄匹配人群的预期生存率相似。尽管淋巴结状态和包膜侵犯情况未知，但结果依然如此。
